PER 1.19% 8.5¢ percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-32

  1. 17,336 Posts.
    lightbulb Created with Sketch. 1336

    Wow! Thanks for the share

    Those comments re: partnering are very juicy!
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.